PetVivo Holdings (NASDAQ:PETV) Inc CEO John Lai tells Proactive the biomedical device company's Spryng technology, which aims to treated osteoarthritis in dogs and horses, has now treated 1,000 animals. Spryng is a veterinarian-administered, intra-articular injection designed to aid in the management of lameness issues, joint pain and osteoarthritis from loss of cartilage or tissue-bone mechanical malfunction caused by joint dysfunction.
PetVivo Holdings CEO says its Spryng tech has now treated 1,000 animals for osteoarthritis
